Dose Response of Exercise for Arthritis Management
Part of paid clinical trials in Columbia, South Carolina.
- Sponsor
- University of South Carolina
- Study ID
- NCT06880653
- Status
- Recruiting
Conditions
- Arthritis
- Fibromyalgia (FM)
- Gout
- Lupus Erythematosus, Systemic
- Osteoarthritis
- Rheumatoid Arthritis (RA)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- DREAM Adaptive Intervention — BEHAVIORAL6-month physical activity program (Dose Response of Exercise for Arthritis Management (DREAM)) which includes monthly phone coaching, Walk With Ease Guidebook, behavioral lessons, and a Fitbit. Participants may receive additional contact (email, text, or phone) if they struggle to meet activity goal.
Study Details
The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.
Key Dates
- Start date
- Mar 28, 2025
- Status verified
- Apr 2026
- Primary completion
- Oct 1, 2028
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 285 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 45 minutes/weekParticipants will be given a goal of 45 minutes/week of moderate-to-vigorous intensity physical activity
- Experimental: 90 minutes/weekParticipants will be given a goal of 90 minutes/week of moderate-to-vigorous intensity physical activity
- Experimental: 150 minutes/weekParticipants will be given a goal of 150 minutes/week of moderate-to-vigorous intensity physical activity
Primary Outcome Measure
Physical function (6 Minute Walk Test) [ Time Frame: Baseline to 6 months ]
Central Contacts
- Ellen Wingard803-777-1889
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of South Carolina | Columbia | South Carolina | 29208 |
Find similar trials in Columbia, SC
By condition
By specialty
By research site
Related Studies
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePHASE2/PHASE3 · Recruiting · Olatec Therapeutics LLC · Birmingham, Alabama
- A Study of Dotinurad Versus Allopurinol in Participants With GoutPHASE3 · Recruiting · Crystalys Therapeutics · Birmingham, Alabama
- A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle SystemRecruiting · Stryker Trauma and Extremities · Morton Grove, Illinois
- Studies of the Natural History of Rheumatic DiseasesRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland